GLP-1 plays an important role in regulating appetite by creating the sensation of feeling full after a meal. UF's findings could have far-reaching implications for developing new medicines designed to treat obesity.
An anticancer drug developed by researchers from the University of Florida College of Pharmacy has become the first drug of its kind allowed to proceed to clinical trial by the U.S. Food and Drug Administration.
Isotretinoin is commonly used by adolescents and young adults to treat more severe cases of acne and has been heavily regulated by the FDA to prevent its use during pregnancy.
The PhRMA Foundation solicited proposals on how value assessment can better capture evidence regarding diverse populations and drivers of health disparities.
UF pharmacy researchers have found a potential new way of targeting a population of immune-suppressive T cells that could possibly benefit a large population of cancer patients, including those who will not respond to other immunotherapies.
Dr. Hendrik Luesch and a team of researchers have discovered a novel marine natural product that binds to a new site of tubulin, an important target for cancer drugs.
The award recognizes exceptional teaching in graduate doctoral education and excellence in mentoring doctoral students throughout their dissertation project.
Dr. Chris McCurdy explains how science is attempting to answer safety questions around kratom in this Conversation story.
McCurdy began researching kratom in 2005 and the study represents the first time his team’s kratom research has appeared on a journal cover.
The study led by Siobhan Malany, Ph.D., will help scientists understand microgravity effects on human muscle cells and could aid the development of new therapies for age-related muscle loss on Earth.